Xiu‐Xian Wu
- Urology top 10%
-
- Drug Transport and Resistance Mechanisms 3
- Cancer-related Molecular Pathways 3
-
- Cell death mechanisms and regulation 12
- RNA Interference and Gene Delivery 2
- Cancer therapeutics and mechanisms 2
-
- Bladder and Urothelial Cancer Treatments 5
-
- Hepatitis B Virus Studies 5
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Yoshiyuki KakehiOsamu OgawaXinghua JinOsamu YoshidaYouichi MizutaniYu ZengToshiro TerachiHiroyuki Tsunemori
- Cited by
- UrologyOncologyBiotechnology
- Partner nations
- JapanChinaUnited States
In The Last Decade
Xiu‐Xian Wu
26 papers receiving 477 citations
Peers
Comparison fields: 5 of 76
- Urology 51
- Oncology 144
- Biotechnology 39
- Cancer Research 66
- Molecular Biology 295
Countries citing papers authored by Xiu‐Xian Wu
This map shows the geographic impact of Xiu‐Xian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu‐Xian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu‐Xian Wu more than expected).
Fields of papers citing papers by Xiu‐Xian Wu
This network shows the impact of papers produced by Xiu‐Xian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu‐Xian Wu. The network helps show where Xiu‐Xian Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiu‐Xian Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 21 | |
| 3 | 2016 | 8 | |
| 4 | 2014 | 10 | |
| 5 | 2012 | 33 | |
| 6 | 2011 | 6 | |
| 7 | 2009 | 4 | |
| 8 | 2008 | 6 | |
| 9 | 2007 | 17 | |
| 10 | 2005 | 33 | |
| 11 | 2004 | 5 | |
| 12 | 2004 | 36 | |
| 13 | 2004 | 1 | |
| 14 | Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. | 2004 | 32 |
| 15 | 2001 | 10 | |
| 16 | 2001 | 37 | |
| 17 | 2000 | 11 | |
| 18 | Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. | 2000 | 67 |
| 19 | 1999 | 2 | |
| 20 | 1997 | 10 |
About Xiu‐Xian Wu
Xiu‐Xian Wu is a scholar working on Urology, Oncology and Molecular Biology, having authored 26 papers that have together received 482 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (12 papers), Bladder and Urothelial Cancer Treatments (5 papers), Hepatitis B Virus Studies (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Mechanisms and Therapy (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Urology (51 citations), Oncology (144 citations) and Biotechnology (39 citations). Xiu‐Xian Wu has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Yoshiyuki Kakehi, Osamu Ogawa, Xinghua Jin, Osamu Yoshida, Youichi Mizutani, Osamu Ogawa, Yu Zeng, Toshiro Terachi, Hiroyuki Tsunemori and Yoichi Mizutani. Their work appears in journals such as Clinical Cancer Research, The Journal of Urology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.